Also, the study highlights lncRNA MALAT1 as a consistent key prognostic factor for cell proliferation in DLBCL, with subsequent reductions in cell division in DLBCL cell lines with MALAT1 knockdown, raising questions about its potential therapeutic role as well [98]. Here, MALAT1 is linked to diffuse large B-cell lymphoma.